Pregled bibliografske jedinice broj: 192540
Assessment of serum albumin cobalt binding assay in patients suspected suffer from acute myocardial infarction
Assessment of serum albumin cobalt binding assay in patients suspected suffer from acute myocardial infarction // Clinical Chemistry and Laboratory Medicine / Siest, Gerard (ur.).
Berlin : New York: Walter de Gruyter, 2004. (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 192540 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Assessment of serum albumin cobalt binding assay in patients suspected suffer from acute myocardial infarction
Autori
Dravinski, Željka ; Rumenjak, Vlatko ; Miličević, Goran ; Bakula, Miro
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Clinical Chemistry and Laboratory Medicine
/ Siest, Gerard - Berlin : New York : Walter de Gruyter, 2004
Skup
International Swiss MedLab 2004 and 8th Alps Adria Congress / Laboratory Medicine: From Atomic absorption to Zeta-Globin
Mjesto i datum
Luzern, Švicarska, 05.10.2004. - 09.10.2004
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
albumin; cobalt; myocardial infarction
Sažetak
Myocardial ischemia results from the lack of adequate blood perfusion to the myocytes, leading to a deficiency of oxygen and nutrients. Recently, the reduced binding of Co (II) to serum albumin has been found to be useful in the diagnosis of acute myocardial ischemia. The aim of this study was to assess the value of Co (II)-albumin binding assay in patients with suspected myocardial injury in the setting of an emergency department. Methods: We evaluated 66 healthy persons (aged 30 – 56 yrs) as the reference group, and 96 consecutive patients (aged 49– 82), with the history of non-traumatic acute chest pain, starting less than 6 hrs before admittance to the emergency department, suggesting myocardial ischemia or an acute coronary syndrome. Patients blood samples were tested by standard cardiac disease markers (troponin I, CKMB) (Dimension Expand, Dade Behring) and a Co (II)-albumin binding assay (colorimetric assay with dithiothreitol). Results: Values in the healthy group were normally distributed: mean value was 0, 481 ABSU (absorbance unit), SD 0, 071 ABSU, and 95% confidence interval were 0, 464– 0, 499 ABSU. Patients had significant higher assay levels (mean value ± ; ; SD): 0, 589± ; ; 0, 164 ABSU compared with healthy persons (p < 0, 01). The patients with acute myocardial infarction (N=19) had slightly higher assay level 0, 597± ; ; 0, 092 ABSU related to patients with other cardiac illness, but the difference was not statistically significant (p>0, 05). Utilizing a cutoff values of 0, 591 ABSU, selected from ROC analysis, the sensitivity was 94%, the specificity was 50% (for myocardial ischemia), the negative predictive value was 98% and the positive predictive value was 9%. Comments and conclusion: Results of this study indicate that patients with evidence of myocardial ischemia and acute coronary syndrome have reduced cobalt binding capacity to albumin. We conclude that this assay may prove to be an early and useful biochemical marker of cardiac ischemia.
Izvorni jezik
Engleski
Znanstvena područja
Temeljne medicinske znanosti